CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- 4 Open-market sale Director sold 11,359 shares at an average $45.04 ($511,658)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $43.76 ($2,187,790)
- 4 Open-market sale Chief Business Officer sold 55,000 shares at an average $43.99 ($2,419,344)
- 4 Open-market sale Chief Operating Officer sold 30,000 shares at an average $43.24 ($1,297,065)
- 4 Open-market sale Director sold 19,580 shares at an average $45.10 ($883,054)
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $44.53 ($667,884)
- 4 Open-market sale President & Chief R&D Officer sold 220,000 shares at $40.04 ($8,808,800)
- 4 Option exercise Chief Business Officer acquired 50,704 shares (option exercise)
- 4 Open-market sale Director sold 4,319 shares at $41.95 ($181,182)
- 4 Open-market sale Director sold 65,029 shares at an average $42.28 ($2,749,721)
- 4 Open-market sale Chief Financial Officer sold 25,000 shares at an average $43.45 ($1,086,200)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 16 · 316 filings